|Last Price$88.44||Day Change (%)-0.77%|
|Open Price$88.77||Day Change ($)-0.69|
|Day Range88.21–88.77||52-Week Range70.95–91.66|
As of Fri 07/25/2014 02:54 PM EST | USD
Drug Companies Oppose Moves to Reimburse Off-Label Medicine
Allscripts MDRX reported first-quarter results that were within the range of our expectations. We are maintaining our fair value estimate. The company generated $65 million in revenue, a 54% increase from the year-ago period. The strong revenue growth was propelled by an 81% revenue increase in the ...
Research and Markets: Global Nicotine Patch Market 2014-2018
Research and Markets: Global Animal (Companion & Production) Healthcare Market 2014-2019 Featuring Key Companies, Zoetis, Merck, Merial, Bayer and Novartis
ADR Shares End Lower; SAP Shares Trade Actively
Research and Markets: Cancer Immunotherapy Market & Clinical Pipeline Insight 2014
Novartis NVS announced Friday that it is removing Zelnorm for irritable bowel syndrome from the U.S. market at the request of the Food and Drug Administration. We think Zelnorm could eventually return to pharmacy shelves in the United States, but we have drastically reduced our estimate of sales ...
VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman